![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
87
PharmaCompass offers a list of Fluorophosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fluorophosphate manufacturer or Fluorophosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fluorophosphate manufacturer or Fluorophosphate supplier.
PharmaCompass also assists you with knowing the Fluorophosphate API Price utilized in the formulation of products. Fluorophosphate API Price is not always fixed or binding as the Fluorophosphate Price is obtained through a variety of data sources. The Fluorophosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium Monofluorophosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Monofluorophosphate, including repackagers and relabelers. The FDA regulates Sodium Monofluorophosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Monofluorophosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Monofluorophosphate supplier is an individual or a company that provides Sodium Monofluorophosphate active pharmaceutical ingredient (API) or Sodium Monofluorophosphate finished formulations upon request. The Sodium Monofluorophosphate suppliers may include Sodium Monofluorophosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Monofluorophosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Monofluorophosphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Monofluorophosphate active pharmaceutical ingredient (API) in detail. Different forms of Sodium Monofluorophosphate DMFs exist exist since differing nations have different regulations, such as Sodium Monofluorophosphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Monofluorophosphate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Monofluorophosphate USDMF includes data on Sodium Monofluorophosphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Monofluorophosphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Monofluorophosphate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium Monofluorophosphate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium Monofluorophosphate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium Monofluorophosphate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium Monofluorophosphate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium Monofluorophosphate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium Monofluorophosphate suppliers with NDC on PharmaCompass.
Sodium Monofluorophosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Monofluorophosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Monofluorophosphate GMP manufacturer or Sodium Monofluorophosphate GMP API supplier for your needs.
A Sodium Monofluorophosphate CoA (Certificate of Analysis) is a formal document that attests to Sodium Monofluorophosphate's compliance with Sodium Monofluorophosphate specifications and serves as a tool for batch-level quality control.
Sodium Monofluorophosphate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Monofluorophosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Monofluorophosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Monofluorophosphate EP), Sodium Monofluorophosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Monofluorophosphate USP).